Apogem Capital’s Infinera Corporation Common Stock INFN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-151,631
Closed -$734K 121
2022
Q3
$734K Hold
151,631
0.73% 41
2022
Q2
$813K Hold
151,631
0.74% 40
2022
Q1
$1.31M Buy
151,631
+2,000
+1% +$17.2K 0.9% 27
2021
Q4
$1.44M Sell
149,631
-23,313
-13% -$198K 0.94% 24
2021
Q3
$1.44M Sell
172,944
-16,455
-9% -$149K 0.92% 26
2021
Q2
$1.93M Buy
189,399
+39,300
+26% +$381K 1.23% 18
2021
Q1
$1.45M Sell
150,099
-19,116
-11% -$187K 0.98% 21
2020
Q4
$1.77M Buy
+169,215
New +$1.34M 1.18% 22

Other funds holding INFN

Apogem Capital's INFN Position: Q4 2022 in Review

Apogem Capital sold out of Infinera Corporation Common Stock (INFN) in Q4 2022, closing a stake of 151,631 shares — an estimated $734K sold.

Apogem Capital first reported a position in INFN in Q4 2020 and held it in 8 quarters. The position peaked at $1.93M in Q2 2021. 208 funds tracked by Wall St. Rank hold INFN as of Q4 2022.

  • Apogem Capital reported no remaining Infinera Corporation Common Stock position as of Q4 2022 after selling out during the quarter.
  • Apogem Capital sold 151,631 Infinera Corporation Common Stock shares in Q4 2022, an estimated $734K.
  • Apogem Capital first reported a position in Infinera Corporation Common Stock in Q4 2020 and held it in 8 quarters.
  • Apogem Capital's Infinera Corporation Common Stock position peaked at $1.93M in Q2 2021.
  • 208 funds tracked by Wall St. Rank held Infinera Corporation Common Stock as of Q4 2022.

Based on Apogem Capital's 13F filing for Q4 2022, filed 13 Feb 2023.